The analysis of CPTAC showed that BiP protein is lowest in the luminal breast cancer molecular subtypes as well as in tumors expressing ER, and, logically, the BiP-L group had significant overrepresentation of the ER signaling pathway (Table 3). This evidence concerns the gene HSPA5 and breast carcinoma.